Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
Mistletoe therapy aims to stop osteosarcoma relapse
Disease control Recruiting nowThis study tests a mistletoe extract (Iscador P) in 32 patients whose osteosarcoma has returned in the lungs and has been surgically removed. The goal is to see if the treatment can delay or prevent the cancer from coming back. Participants receive injections of the extract and a…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Radioactive drug aims to shrink aggressive prostate tumors before surgery
Disease control Recruiting nowThis Phase 2 trial is testing whether a single dose of Lu-177-PSMA-617 (Pluvicto), a radioactive drug that targets prostate cancer cells, can shrink or eliminate high-risk prostate tumors before surgery. About 54 men with aggressive prostate cancer (Gleason score 8 or higher) wil…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New transplant combo aims to boost survival in blood cancer patients
Disease control Recruiting nowThis phase 2 trial is testing a new combination of chemotherapy, radiation, and immune-suppressing drugs for people aged 18-65 with blood cancers who need a stem cell transplant. The goal is to see if this regimen improves survival one year after transplant. About 209 participant…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Simple blood test could decide best therapy for advanced lung cancer
Disease control Recruiting nowThis phase 2 trial tests whether a blood test that tracks tumor DNA can guide treatment for people with advanced non-small cell lung cancer. Participants will receive either immunotherapy alone or immunotherapy plus chemotherapy, based on their blood test results. The goal is to …
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug cocktail aims to boost stem cell harvest in myeloma patients
Disease control Recruiting nowThis early-phase study tests a combination of drugs (carfilzomib, cyclophosphamide, dexamethasone, and G-CSF) to see if it can safely and effectively collect stem cells for transplant in people with multiple myeloma. The goal is to find the best dose of carfilzomib that causes th…
Phase: PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail aims to boost myeloma remission before transplant
Disease control Recruiting nowThis study tests a combination of three drugs—carfilzomib, iberdomide, and dexamethasone—in people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal is to see if this mix is safe and effective at shrinking the cancer before transplant. Ab…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New clinic aims to keep heart failure patients out of the hospital
Disease control Recruiting nowThis study tests a multidisciplinary clinic that provides heart failure patients with educational videos, a self-management kit, and follow-up phone calls after hospital discharge. The goal is to reduce 30-day readmission rates and improve patient satisfaction. The trial enrolls …
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Flomax may keep men from needing catheters after lung cancer surgery
Disease control Recruiting nowThis study tests whether taking Tamsulosin (Flomax) for a week before surgery can help older men urinate normally after thoracic cancer surgery. About 46 men aged 55 and older will take the drug and have their bladder checked after surgery. The goal is to see if fewer men need ca…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Heart rehab may boost stroke recovery, new study hopes to prove
Disease control Recruiting nowThis study looks at whether a cardiac rehabilitation program can improve recovery for people who have had a stroke. Researchers will enroll 150 stroke survivors and add cardiac rehab to their usual care. They will measure walking ability, daily function, and whether the program r…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a special PET scan spot returning prostate cancer after targeted therapy?
Diagnosis Recruiting nowThis study is testing whether a PSMA-PET scan using a radioactive tracer called 18F-rhPSMA-7.3 can accurately detect prostate cancer that has come back after focal gland treatment. About 70 men who had focal therapy for intermediate-risk prostate cancer will receive the scan, and…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Can a prostate drug stop Post-Surgery urinary problems?
Prevention Recruiting nowThis study tests whether taking Flomax (tamsulosin) before and after chest surgery can prevent urinary retention in men aged 50 and older. Urinary retention is a common complication that can require a catheter and cause discomfort. The trial will compare two dosing schedules—star…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Can teletherapy help veterans with brain injury feel less emotionally numb?
Symptom relief Recruiting nowThis study compares two remote training programs for 300 people who have had a mild traumatic brain injury (concussion) and struggle with emotional awareness and regulation. One program teaches participants to recognize and label their emotions, while the other focuses on general…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Lower dose of common painkiller may work just as well for kidney stone pain
Symptom relief Recruiting nowThis study tests whether a 15mg dose of the painkiller ketorolac works as well as a 30mg dose for relieving kidney stone pain in the emergency department. About 86 adults with severe pain will receive one of the two doses, and their pain levels will be tracked over several hours.…
Phase: PHASE4 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New program aims to ease cancer Patients' scan anxiety
Symptom relief Recruiting nowThis study is testing a stress management program designed for people with lung cancer who are waiting for routine scan results. The program includes a short orientation, self-guided web modules with stress management exercises, and coaching calls. Researchers want to see if the …
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New study compares two types of therapy for postpartum depression in NICU moms
Symptom relief Recruiting nowThis study tests two types of talk therapy—cognitive behavioral therapy (CBT) and interpersonal therapy (IPT)—for postpartum depression in mothers whose babies are in the NICU. About 72 mothers will receive either 4 weeks of one therapy or 8 weeks of both, to see which approach r…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New study explores emotional training for brain injury recovery
Knowledge-focused Recruiting nowThis study looks at whether two different training programs can improve emotional health in people who have had a moderate to severe traumatic brain injury. About 48 adults will take part in 8 one-on-one sessions over a month, learning either to recognize emotions or adopt health…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Rare brain tumor registry launches to unlock secrets of ETMR
Knowledge-focused Recruiting nowThis study creates a worldwide registry for children diagnosed with Embryonal Tumor with Multilayer Rosettes (ETMR), a rare and aggressive brain tumor. Researchers will collect medical records, tumor tissue, and treatment outcomes from up to 100 patients of any age. The goal is t…
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
10,000 volunteers join quest to spot cancer earlier
Knowledge-focused Recruiting nowThis study is building a registry of 10,000 adults at increased risk for cancer. Participants fill out questionnaires and may provide genetic samples. The goal is to learn more about cancer risk factors and improve screening, not to test a new treatment.
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Simple ultrasound may predict breathing trouble in late preterm newborns
Knowledge-focused Recruiting nowThis study looks at whether a lung ultrasound done shortly after birth can predict which late preterm babies (born 34–36 weeks) will have breathing problems in the first two days of life. Researchers will compare three different ultrasound scoring methods. The goal is to help doc…
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
ER Check-Ups could boost lung cancer screening rates
Knowledge-focused Recruiting nowThis study tests a new way to increase lung cancer screening in people at high risk. Researchers will use the emergency department to identify eligible patients and offer them extra help to get a low-dose CT scan. The goal is to see if this approach works better than standard car…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC